Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Pain 2Neoplasms 2Weight Loss 1Trigger Finger Disorder 1Prostatic Neoplasms 1Pituitary Neoplasms 1Patient Satisfaction 1Nose Neoplasms 1Mucositis 1Menorrhagia 1Median Neuropathy 1Lymphoma, Follicular 1Leiomyoma 1Hemorrhage 1Head and Neck Neoplasms 1Ganglion Cysts 1Esthesioneuroblastoma, Olfactory 1De Quervain Disease 1Cognitive Dysfunction 1Cachexia 1Adenomyosis 1Abnormalities, Radiation-Induced 1

Interventions

Radiotherapy 7Cisplatin 6Fibroblast Growth Factor 7 3Water 2Radiation 2Low-Level Light Therapy 2Injections 2peppermint oil 1pegfilgrastim 1oxycodone-acetaminophen 1kang-lai-te 1cyclohexaneacetic acid 1brilacidin 1anise oil 1acetaminophen, hydrocodone drug combination 1Xylitol 1Tramadol 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sorbic Acid 1Selenomethionine 1Saline Solution 1RRx-001 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Pain Management 1Neck Dissection 1Methods 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mucositis × Ibuprofen × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡